, Australia
/Ekahardiwito from Envato

MS Amlin opens Sydney office to expand APAC reinsurance business

Matt Botfield was appointed as head of Australia and New Zealand.

MS Amlin is opening a new branch office in Sydney, pending Lloyd’s approval, as part of its Asia Pacific Reinsurance business, MS Amlin Pacific Pte. Ltd. 

The company has appointed Matt Botfield as head of Australia and New Zealand.  
MS Amlin’s Asia Pacific reinsurance operations, led by regional CEO Will Ho, provide casualty, property, and specialty reinsurance solutions.

The company is expanding its presence in Australia and New Zealand, where a growing share of its regional business originates.  

Botfield will manage the existing client portfolio and broker relationships in Australia and New Zealand whilst overseeing new business development. 

He will also leverage MS Amlin’s underwriting capabilities to develop solutions for clients in the region. 

The Australian operations will complement the current portfolio written from London.  

Botfield previously served as Chief Operating Officer for Greater China at Aon Reinsurance China and CEO of Alternate Insurance Authority Hong Kong. 

He spent 14 years at Aon Benfield in senior roles, including Head of Property Australia and New Zealand.  
 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.